218 related articles for article (PubMed ID: 22157016)
1. SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity.
Pan M; Yuan H; Brent M; Ding EC; Marmorstein R
J Biol Chem; 2012 Jan; 287(4):2468-76. PubMed ID: 22157016
[TBL] [Abstract][Full Text] [Related]
2. Molecular architecture of the human protein deacetylase Sirt1 and its regulation by AROS and resveratrol.
Lakshminarasimhan M; Curth U; Moniot S; Mosalaganti S; Raunser S; Steegborn C
Biosci Rep; 2013 May; 33(3):. PubMed ID: 23548308
[TBL] [Abstract][Full Text] [Related]
3. Peptide switch is essential for Sirt1 deacetylase activity.
Kang H; Suh JY; Jung YS; Jung JW; Kim MK; Chung JH
Mol Cell; 2011 Oct; 44(2):203-13. PubMed ID: 22017869
[TBL] [Abstract][Full Text] [Related]
4. Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1.
Pfister JA; Ma C; D'Mello SR
PLoS One; 2019; 14(4):e0215208. PubMed ID: 30973934
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of human SIRT1.
Davenport AM; Huber FM; Hoelz A
J Mol Biol; 2014 Feb; 426(3):526-41. PubMed ID: 24120939
[TBL] [Abstract][Full Text] [Related]
6. The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.
Zhao X; Allison D; Condon B; Zhang F; Gheyi T; Zhang A; Ashok S; Russell M; MacEwan I; Qian Y; Jamison JA; Luz JG
J Med Chem; 2013 Feb; 56(3):963-9. PubMed ID: 23311358
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Sirt1 NAD+-dependent Protein Deacetylase Inhibition by Cysteine S-Nitrosation.
Kalous KS; Wynia-Smith SL; Olp MD; Smith BC
J Biol Chem; 2016 Dec; 291(49):25398-25410. PubMed ID: 27756843
[TBL] [Abstract][Full Text] [Related]
8. Comparative deacetylase activity of wild type and mutants of SIRT1.
Malik R; Kashyap A; Bansal K; Sharma P; Rayasam GV; Davis JA; Bora RS; Ray A; Saini KS
Biochem Biophys Res Commun; 2010 Jan; 391(1):739-43. PubMed ID: 19944070
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol.
Cao D; Wang M; Qiu X; Liu D; Jiang H; Yang N; Xu RM
Genes Dev; 2015 Jun; 29(12):1316-25. PubMed ID: 26109052
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic structure of a small molecule SIRT1 activator-enzyme complex.
Dai H; Case AW; Riera TV; Considine T; Lee JE; Hamuro Y; Zhao H; Jiang Y; Sweitzer SM; Pietrak B; Schwartz B; Blum CA; Disch JS; Caldwell R; Szczepankiewicz B; Oalmann C; Yee Ng P; White BH; Casaubon R; Narayan R; Koppetsch K; Bourbonais F; Wu B; Wang J; Qian D; Jiang F; Mao C; Wang M; Hu E; Wu JC; Perni RB; Vlasuk GP; Ellis JL
Nat Commun; 2015 Jul; 6():7645. PubMed ID: 26134520
[TBL] [Abstract][Full Text] [Related]
11. An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity.
Krzysiak TC; Thomas L; Choi YJ; Auclair S; Qian Y; Luan S; Krasnow SM; Thomas LL; Koharudin LMI; Benos PV; Marks DL; Gronenborn AM; Thomas G
Mol Cell; 2018 Dec; 72(6):985-998.e7. PubMed ID: 30415949
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Tissue-Restricted Isoform of SIRT1 Defines a Regulatory Domain that Encodes Specificity.
Deota S; Chattopadhyay T; Ramachandran D; Armstrong E; Camacho B; Maniyadath B; Fulzele A; Gonzalez-de-Peredo A; Denu JM; Kolthur-Seetharam U
Cell Rep; 2017 Mar; 18(13):3069-3077. PubMed ID: 28355560
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the roles of the N- and C-flanking residues of acetyllysine substrates for SIRT1 activity.
Meledin R; Brik A; Aharoni A
Chembiochem; 2013 Mar; 14(5):577-81. PubMed ID: 23426869
[TBL] [Abstract][Full Text] [Related]
14. The NAD(+)-dependent protein deacetylase activity of SIRT1 is regulated by its oligomeric status.
Guo X; Kesimer M; Tolun G; Zheng X; Xu Q; Lu J; Sheehan JK; Griffith JD; Li X
Sci Rep; 2012; 2():640. PubMed ID: 22962634
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.
Bouras T; Fu M; Sauve AA; Wang F; Quong AA; Perkins ND; Hay RT; Gu W; Pestell RG
J Biol Chem; 2005 Mar; 280(11):10264-76. PubMed ID: 15632193
[TBL] [Abstract][Full Text] [Related]
16. SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice.
Seifert EL; Caron AZ; Morin K; Coulombe J; He XH; Jardine K; Dewar-Darch D; Boekelheide K; Harper ME; McBurney MW
FASEB J; 2012 Feb; 26(2):555-66. PubMed ID: 22006156
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationship modeling reveals the minimal sequence requirement and amino acid preference of sirtuin-1's deacetylation substrates in diabetes mellitus.
Shao X; Kong W; Li Y; Zhang S
J Bioinform Comput Biol; 2022 Jun; 20(3):2250008. PubMed ID: 35451939
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation of SIRT1 enhances its deacetylase activity and promotes cytoprotection under stress.
Han C; Gu Y; Shan H; Mi W; Sun J; Shi M; Zhang X; Lu X; Han F; Gong Q; Yu W
Nat Commun; 2017 Nov; 8(1):1491. PubMed ID: 29133780
[TBL] [Abstract][Full Text] [Related]
19. How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
Kumar A; Chauhan S
Eur J Med Chem; 2016 Aug; 119():45-69. PubMed ID: 27153347
[TBL] [Abstract][Full Text] [Related]
20. Biochemical insight into pseudouridine synthase 7 (PUS7) as a novel interactor of sirtuin, SIRT1.
Dalal S; Deshmukh P; Unni S; Padavattan S; Padmanabhan B
Biochem Biophys Res Commun; 2019 Oct; 518(3):598-604. PubMed ID: 31451225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
